{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:23:23Z","timestamp":1789053803562,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bioorg.2023.106428","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T20:56:52Z","timestamp":1676840212000},"page":"106428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities"],"prefix":"10.1016","volume":"134","author":[{"given":"Wael","family":"A. A. Fadaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseen","family":"A. M. M. Elshaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"T. M. Nemr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"R. A. Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106428_b0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejmech.2015.08.010","article-title":"Shagufta, Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer","volume":"102","author":"Ahmad","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.09.038","article-title":"Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer","volume":"105","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejmech.2017.05.041","article-title":"Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): understanding the chemico-biological interactions through comparative SAR\/QSAR study","volume":"137","author":"Adhikari","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0020","doi-asserted-by":"crossref","unstructured":"Adhikari, Nilanjan; Amin, Sk. Abdul; Saha, Achintya; Jha, Tarun , Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR\/QSAR study. Eur. J. Med. Chem. 137: 365\u2013438. Doi:10.1016\/j.ejmech.2017.05.041.","DOI":"10.1016\/j.ejmech.2017.05.041"},{"key":"10.1016\/j.bioorg.2023.106428_b0025","doi-asserted-by":"crossref","unstructured":"A. Irshad; Shagufta, Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer. Eur. J. Med. Chem. 102: 375\u2013386. doi:10.1016\/j.ejmech.2015.08.010.","DOI":"10.1016\/j.ejmech.2015.08.010"},{"key":"10.1016\/j.bioorg.2023.106428_b0030","doi-asserted-by":"crossref","unstructured":"S. Zafer; E. Merve; B. Bark\u0131n; B. Sevde Nur; Y. Leyla; D. Seref Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl\/heteroaryl)-2-(pyrimidin-2-yl) thiazole derivatives. Bioorg. Med. Chem. 26 (8): 1986\u20131995. doi:10.1016\/j.bmc.2018.02.048.","DOI":"10.1016\/j.bmc.2018.02.048"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106428_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13046-021-02050-1","article-title":"Identification of novel COX-2 \/ CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities","volume":"40","author":"Barbara","year":"2021","journal-title":"J. Experimental & Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106428_b0040","doi-asserted-by":"crossref","unstructured":"Edgar S. D\u0131\u0301az-Cruz, Charles L. Shapiro, and Robert W. Cyclooxygenase Inhibitors Suppress Aromatase Expression and Activity in Breast Cancer Cells. The Journal of Clinical Endocrinology & Metabolism (2005), 90 (5): 2563\u20132570. DOI: 10.1210\/jc.2004-2029.","DOI":"10.1210\/jc.2004-2029"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106428_b0045","first-page":"13","volume":"31","author":"Brueggemeier","year":"2006","journal-title":"Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches Minerva endocrinologica"},{"key":"10.1016\/j.bioorg.2023.106428_b0050","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/jclinpath-2020-206576","article-title":"Detection of COX-2 in liquid biopsy in patients with breast cancer","volume":"73","author":"de Souza","year":"2020","journal-title":"J. Clin. Pathol."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106428_b0055","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jnci\/djy017","article-title":"Effects of celecoxib and low-dose aspirin on outcomes in adjuvant aromatase inhibitor-treated patients: CCTG","volume":"110","author":"Strasser-Weippl","year":"2018","journal-title":"J. National Cancer Institute"},{"issue":"8","key":"10.1016\/j.bioorg.2023.106428_b0060","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1210\/en.2017-00346","article-title":"Central administration of indomethacin mitigates the injury-induced upregulation of aromatase expression and estradiol content in the zebra finch brain","volume":"158","author":"Pedersen","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.bioorg.2023.106428_b0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","article-title":"Nonsteroidal anti- inflammatory drugs and breast cancer risk","volume":"7","author":"Harris","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.bioorg.2023.106428_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canlet.2021.01.003","article-title":"COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar\/fat diet treated mice","volume":"502","author":"Mayer","year":"2021","journal-title":"Cancer lett."},{"key":"10.1016\/j.bioorg.2023.106428_b0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1054\/mehy.1998.0009","article-title":"Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer","volume":"52","author":"Harris","year":"1999","journal-title":"Med. Hypotheses"},{"issue":"14","key":"10.1016\/j.bioorg.2023.106428_b0080","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1016\/j.bmc.2007.05.009","article-title":"O2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studies","volume":"15","author":"Velazquez","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106428_b0085","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/14756360903357585","article-title":"Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives","volume":"25","author":"Bhandari","year":"2010","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106428_b0090","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2000.9304","article-title":"Nitric oxide in mucosal defense: a little goes a long way","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106428_b0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000007506","article-title":"Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage in rats","volume":"59","author":"Takeuchi","year":"1998","journal-title":"Digestion"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106428_b0100","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0016-5085(90)90005-L","article-title":"Afferent nerve-mediated protection against deep mucosal damage in the rat stomach","volume":"98","author":"Holzer","year":"1990","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106428_b0105","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"New Engl. J. Med."},{"issue":"20","key":"10.1016\/j.bioorg.2023.106428_b0110","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2008.08.041","article-title":"Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population","volume":"52","author":"Garcia Rodriguez","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106428_b0115","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1053\/j.gastro.2003.05.015","article-title":"No-Aspirin (NCX 4016)","volume":"125","author":"Mann","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioorg.2023.106428_b0120","doi-asserted-by":"crossref","unstructured":"J.E. Keeble, P.K. Moore, Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxidedonating drugs, Br. J. Pharmacol. 137 (3) (2002) 295\u2013310, https:\/\/doi.org\/10. 1038\/sj.bjp.0704876.","DOI":"10.1038\/sj.bjp.0704876"},{"key":"10.1016\/j.bioorg.2023.106428_b0125","doi-asserted-by":"crossref","unstructured":"K. Rehse, F. Brehme, New NO donors with antithrombotic and vasodilating activities, Part 27. Azide oximes and 1-hydroxytetrazoles, Arch. der Pharm. 333(6) (2000) 157\u2013161, https:\/\/doi.org\/10.1002\/1521-4184(20006)333:6 < 157::aidardp157 > 3.0.co;2-c.","DOI":"10.1002\/1521-4184(20006)333:6<157::AID-ARDP157>3.0.CO;2-C"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106428_b0130","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.freeradbiomed.2005.06.011","article-title":"Selective nitros(yl)ation induced in vivo by a nitric oxide-donating cyclooxygenase-2 inhibitor: a NObonomic analysis","volume":"39","author":"Dhawan","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106428_b0135","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/jm0607247","article-title":"NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties","volume":"50","author":"Chegaev","year":"2007","journal-title":"J. Med. Chem."},{"issue":"65","key":"10.1016\/j.bioorg.2023.106428_b0140","doi-asserted-by":"crossref","first-page":"108890","DOI":"10.18632\/oncotarget.21610","article-title":"Nitric oxide is cytoprotective to breast cancer spheroids vulnerable to estrogen-induced apoptosis","volume":"8","author":"Shafran","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106428_b0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0960-0760(96)00008-8","article-title":"Nitric oxide inhibits aromatase activity: mechanisms of action","volume":"58","author":"Snyder","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106428_b0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/molehr\/3.4.285","article-title":"Nitric oxide inhibits steroidogenesis in cultured porcine granulosa cells","volume":"3","author":"Masuda","year":"1997","journal-title":"Mol. Hum. Reprod."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106428_b0155","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/molehr\/5.5.396","article-title":"Inhibitory effects of nitric oxide on the expression and activity of aromatase in human granulosa cells","volume":"5","author":"Kagabu","year":"1999","journal-title":"Molecular Human Reproduction"},{"key":"10.1016\/j.bioorg.2023.106428_b0160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bioorg.2018.02.018","article-title":"Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile","volume":"77","author":"Abdellatif","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"sup3","key":"10.1016\/j.bioorg.2023.106428_b0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/14756366.2016.1201815","article-title":"Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5diarylpyrazole derivatives","volume":"31","author":"Abdellatif","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106428_b0170","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ardp.201600145","article-title":"Synthesis, Cyclooxygenase inhibition, anti-inflammatory evaluation, and ulcerogenic liability of new 1,3,5-triarylpyrazoline derivatives possessing a methanesulfonyl pharmacophore","volume":"349","author":"Abdellatif","year":"2016","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2023.106428_b0175","doi-asserted-by":"crossref","unstructured":"K. R. Abdellatif, Y. Dong, Q. H. Chen, M. A. Chowdhury, E. E. Knaus, Novel (E)-2(aryl)-3-(4-methanesulfonylphenyl)acrylic ester prodrugs possessing a diazen-1ium-1,2-diolate moiety: design, synthesis, cyclooxygenase inhibition, and nitric oxide release studies, Bioorg. Med. Chem. 15 (21) (2007) 6796\u20136801, https:\/\/doi. org\/10.1016\/j.bmc.2007.07.021.","DOI":"10.1016\/j.bmc.2007.07.021"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106428_b0180","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.bmc.2007.12.006","article-title":"Diazen-1-ium1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies","volume":"16","author":"Abdellatif","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2023.106428_b0185","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1016\/j.bmc.2008.05.028","article-title":"Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities","volume":"16","author":"Abdellatif","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103752","volume":"98","author":"Fadaly","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103132","article-title":"Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities","volume":"91","author":"Abdellatif","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0200","doi-asserted-by":"crossref","first-page":"e202104429","DOI":"10.1002\/slct.202104429","article-title":"Structural insights into pyrazoles as agents against anti-inflammatory and related disorders","volume":"7","author":"Priya","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2023.106428_b0205","doi-asserted-by":"crossref","first-page":"29723","DOI":"10.1039\/D0RA05561A","article-title":"Design, synthesis and biological evaluation of new 2-aminothiazole scaffolds as phosphodiesterase type 5 regulators and COX-1\/COX-2 inhibitors","volume":"10","author":"Hussein","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2023.106428_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104134","article-title":"New fused pyrimidine derivatives with anticancer activity: synthesis, topoisomerase II inhibition, apoptotic inducing activity and molecular modeling study","volume":"103","author":"Nemr","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104446","article-title":"Design, synthesis and antiproliferative evaluation of new tricyclic fused thiazolopyrimidines targeting topoisomerase II: molecular docking and apoptosis inducing activity","volume":"105","author":"Nemr","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0220","doi-asserted-by":"crossref","first-page":"26241","DOI":"10.1039\/D1RA05277B","article-title":"Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition","volume":"11","author":"Nemr","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2023.106428_b0225","article-title":"Design, synthesis and chemoinformatic studies of new thiazolopyrimidine derivatives as potent anticancer agents via phosphodiesterase-5 inhibition and apoptotic inducing activity","author":"Nemr","year":"2022","journal-title":"J. Molecular struct."},{"key":"10.1016\/j.bioorg.2023.106428_b0230","doi-asserted-by":"crossref","unstructured":"R. M. J. J. o. T. B. Botting, Cyclooxygenase: past, present and future. A tribute to John R. Vane (1927\u20132004), 31(1-2) (2006) 208-219, 10.1016\/j. jtherbio.2005.11.008.","DOI":"10.1016\/j.jtherbio.2005.11.008"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106428_b0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00002018-200629020-00002","article-title":"NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options","volume":"29","author":"Naesdal","year":"2006","journal-title":"Drug Saf."},{"key":"10.1016\/j.bioorg.2023.106428_b0240","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2017.02.031","article-title":"Therapeutic journey of 2,4-thiazolidinediones as a versatile scaffold: an insight into structure activity relationship","volume":"129","author":"Naim","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106428_b0245","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1572-0241.2005.50565.x","article-title":"NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality","volume":"100","author":"Cryer","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2023.106428_b0250","doi-asserted-by":"crossref","unstructured":"M. Lazzaroni, G. Bianchi Porro, Gastrointestinal side-effects of traditional nonsteroidal anti-inflammatory drugs and new formulations, Aliment. Pharmacol. Therapeut., 20 (Suppl 2) (2004) 48\u201358, 10.1111\/j.1365-2036. 2004.02037.x.","DOI":"10.1111\/j.1365-2036.2004.02037.x"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106428_b0255","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1365-2125.2003.01934.x","article-title":"Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract","volume":"56","author":"James","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106428_b0260","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/aje\/kwj331","article-title":"Association of selective and conventional nonsteroidal anti-inflammatory drugs with acute renal failure: a population-based, nested case-control analysis","volume":"164","author":"Schneider","year":"2006","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106428_b0265","first-page":"255","article-title":"Severe renal adverse events with arylcarboxylic non-steroidal anti-inflammatory drugs: results of a eight-year French national survey","volume":"61","author":"Mounier","year":"2006","journal-title":"Therapie"},{"issue":"7\u20138","key":"10.1016\/j.bioorg.2023.106428_b0270","first-page":"686","article-title":"Nonsteroidal anti-inflammatory drugs and the kidney","volume":"52","author":"Zadrazil","year":"2006","journal-title":"Vnitr. Lek."},{"issue":"965","key":"10.1016\/j.bioorg.2023.106428_b0275","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/pgmj.2005.039586","article-title":"Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?","volume":"82","author":"Adebayo","year":"2006","journal-title":"Postgrad. Med. J."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106428_b0280","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2165\/00003495-200059040-00017","article-title":"Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain","volume":"59","author":"Clemett","year":"2000","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106428_b0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI200113418","article-title":"Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs","volume":"108","author":"Patrono","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bioorg.2023.106428_b0290","doi-asserted-by":"crossref","first-page":"13383","DOI":"10.1039\/D2NJ00460G","article-title":"Chemistry of 2-Vinylindoles: synthesis and applications","volume":"46","author":"Elshaier","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0295","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bioorg.2018.09.034","article-title":"Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-\u03b3 agonists and anti-inflammatory COX-2 selective inhibitors","volume":"82","author":"Abdellatif","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0300","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1016\/j.bmcl.2014.09.024","article-title":"Synthesis of new 1-(4-methane(amino)sulfonylphenyl)-5-(4-substituted-aminomethylphenyl)-3-trifluoromethyl-1H-pyrazoles: Asearch for novel nitric oxide donor anti-inflammatory agents, Bioorg. & Medicinal","volume":"24","author":"Abdellatif","year":"2014","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106428_b0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2023.106428_b0310","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1016\/j.bmcl.2010.07.054","article-title":"The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life","volume":"20","author":"Wang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106428_b0315","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3797\/scipharm.1408-10","article-title":"Molecular Docking Studies of Phytocompounds from the Phyllanthus Species as Potential Chronic Pain Modulators","volume":"83","author":"Chopade","year":"2014","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2023.106428_b0320","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1021\/jm901705h","article-title":"Highly Potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template","volume":"53","author":"Woo","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0325","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/jm040163o","article-title":"A Shape-Based 3-D scaffold hopping method and its application to a bacterial protein\u2212protein interaction","volume":"48","author":"Grant","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0330","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1021\/jm8001058","article-title":"Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints","volume":"51","author":"Venhorst","year":"2008","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106428_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103092","article-title":"Structure- and ligand-based in silico studies towards the repurposing of marine bioactive compounds to target SARS-CoV-2","volume":"14","author":"Fayed","year":"2021","journal-title":"Arabian J. Chem."},{"key":"10.1016\/j.bioorg.2023.106428_b0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","article-title":"Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen","volume":"34","author":"Boyd","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2023.106428_b0345","first-page":"622","article-title":"The National Cancer Institute: cancer drug discovery and development program","volume":"19","author":"Grever","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bioorg.2023.106428_b0350","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106428_b0355","first-page":"2515","article-title":"Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production","volume":"51","author":"Vistica","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106428_b0360","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/iub.1188","article-title":"Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells","volume":"65","author":"Tolba","year":"2013","journal-title":"IUBMB life"},{"key":"10.1016\/j.bioorg.2023.106428_b0365","doi-asserted-by":"crossref","unstructured":"D. A. Wink, L. A. Ridnour, S. P. Hussain, C. C. Harris, The reemergence of nitric oxide and cancer, Nitric Oxide: Biol. Chem. 19 (2) (2008) 65\u201367, https:\/\/doi.org\/10. 1016\/j.niox.2008.05.003.","DOI":"10.1016\/j.niox.2008.05.003"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:40:05Z","timestamp":1758616805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":73,"alternative-id":["S0045206823000883"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106428","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106428"}}